Effectiveness Study "HospiAvontuur":

November 18, 2018 updated by: PXL University College

Effectiveness Study "HospiAvontuur": Validation of a Serious Game for the Preparation of Children (4 - 6 Year Old) for a Hospital Admission for an Elective Surgical Procedure (ORL Surgery).

Preoperative anxiety is frequently experienced by children undergoing anaesthesia and surgery and being separated from parents during the operation. It is associated with a significant number of adverse outcomes such as maladaptive behavioural changes and increased postoperative analgesic requirements. Pharmacological interventions such as midazolam are widely used to decrease preoperative anxiety in children. However, premedication may be associated with undesirable effects such as paradoxical reactions, prolonged sedation and adverse behavioural changes.The aim of this study is to develop and use a serious game, HospiAvontuur, which can be used during the preparation of children for an admission at the hospital. By using this game the researchers aim to reduce the usage of pharmacological interventions and to increase the use of non-pharmacological interventions, such as HospiAvontuur.

Study Overview

Status

Unknown

Detailed Description

The research questions for the primary outcome are formulated in 5 zero hypotheses:

Zero hypothesis 1: there is no difference in anxiety levels measured as mYPAS-SF on T1 between the two groups.

Zero hypothesis 2: there is no difference in anxiety levels measured as mYPAS-SF on T2 between the two groups.

Zero hypothesis 3: there is no difference in anxiety levels measured as ICC on T2 between the two groups.

Zero hypothesis 4: there is no difference in anxiety levels measured as VAK 4-12 on T0 between the two groups.

Zero hypothesis 5: there is no difference in change in anxiety levels measured as difference between mYPAS-SF on 2 moments (T1 versus T2) between the two groups.

The research questions for the secondary outcomes are formulated Zero hypothesis 6: there is no difference in level of emergence delirium (ED) measured during the postoperative period (T3) in the recovery room, at 4 moments, as PAED scale, between the two groups.

Zero hypothesis 7: there is no difference in level of postoperative pain measured during the postoperative period in the recovery room, as FPS-R scale and OPS scale, between the two groups.

Zero hypothesis 8: there is no difference in level of pain as FPS-R scale and problematic behaviour (PB) as modified and simplified version of the PHBQ questionnaire on day 2 and at the end of week 1 after the operation.

Design The design of the study will be a single blinded randomized clinical trial. Children will be divided in 2 research groups: an intervention group (children who will play the game HospiAvontuur as a non-pharmacological at home preparation prior to the hospital admission. These children will not receive any pharmacological preparation - Midazolam - at the hospital) and a control group (children who do not play the game at home and do receive a pharmacological preparation - Midazolam - at the hospital). Participants will be randomly assigned to the intervention group or the control group using a computer-generated random allocation sequence, created by the study investigator (F.V.). Each patient will receive a unique randomized test number.

Outcome measures As primary outcome for this research project, 2 kinds of anxiety will be measured. First the trait anxiety will be measured. Therefore the VAK 4-12 (Vragenlijst Angst Kinderen - attachment 1) will be used. To measure the state anxiety, the mYPAS-SF and the ICC will be used.

Emergence delirium: ED will be measured in the recovery room, using the five-point Pediatric Anesthesia Emergence Delirium Scale (PAED).

Pain will be measured in the recovery room, using the four-point Objective Pain Scale (OPS), at two time moments: the time of the first awaking of the child and the moment of discharge from the recovery room. For the purpose of this study, the FPS-R (Faces Pain Scale - Revised), a self-reporting pain scale, will also be used on the same time moments. This instrument will be used by a researcher.

On two time moments: 2 days after surgery and at the end of the first week after surgery, parents will receive a phone call from one of the doctors from the anesthesia department or the study investigator.

Both postoperative pain and problematic behaviour will be questioned during a semi-structured interview. The FPS-R will be used for pain measurement and 10 questions will be asked in order to get a good impression of the child's postoperative behaviour (table 1).

One version of the FPS-R will be handed over to the parents and the child at the moment of discharge from the hospital. Parents will be informed that they can expect a phone call from a researcher or an anesthesia staff member and that some questions including the pain perception will be asked.

Power analysis

Based on the duration of the research project, the expected subjects that could be included in the study, the controlling of the variables and based on previous research from Marechal et al (2016), the following power analysis was calculated:

A total research population of 164 subjects (82 subjects per group), would be required to demonstrate a 8 point difference in m-YPAS score at time of induction (level of significance of p < 0.05 and power of 80%). The mean mYPAS score at time of induction, after MDZ premedication in the study of Marechal et al (2016) was 43.74 (SD = 18.32).

Data received from the OR database (1/12/2015 - 30/11/2016) show that approximately 300 children undergo ORL surgery over 12 months. Our study will start at 01/09/2017 and will end on 31/05/2018 (a period of 9 months). During this period approximately 225 children will be operated in the OR. As surgeons are able to set parents at ease to participate in the study because no harm will done to the child and since children nor parents won't notice the presence of the researcher in the OR (performing the observations), it is expected that most parents and children will participate. However, some parents are not keen on scientific studies. Others will not be interested in participating because their mind is set on the child that needs surgery rather than on other things. Moreover, the number of children undergoing ORL surgery is not always constant and there is also a risk of loss-to-follow-up. Therefore, the sample size of 164 patients will be inflated to 90 participants per group (180 in total) to account for a possible 10% loss-to-follow-up.

Statistics The significance of the differences between the two groups for the scores of VAK4-12, mYPas at T1, mTPAS at T2, ICC will be tested with Mann-Whitney U-tests. The significance of the differences between T2 and T1 for the two groups will be measured with two-way ANOVA. All statistical analyses will be done in the package SAS.

Ethics During the recruiting of the participants it is important that both parents and children are fully informed about the randomization process. In general, playing a serious game is considered to be a pleasant activity and children who are assigned to the intervention group may consider themselves to be lucky. On the other hand parents may think that playing a game and therefore not receiving the standard pharmacological treatment may be considered as unfavourable. When providing information to parents it is crucial to make it clear that both the non-pharmacological as the pharmacological strategies have a scientific basis and that no harm will be done to the children.

The non-pharmacological preparation of children before surgery is considered standard procedure in many hospitals. At the Jessa Hospital this is not yet the case although questions about this issue have been risen some time ago, according to the anaesthesia department. At this moment there is no specific non-pharmacological alternative in use. Therefore this research project could be an answer to this issue. The results from the study could support the decision in whether a non-pharmacological preparation program could be introduced.

During the observations of the children in the preoperative holding area and in the operating room during anesthesia induction, it is possible that the researcher or the anesthesiologist can happen to hear some information from the child or the parent about gaming experiences. This can be the case when the child recognizes specific information in the OR that he/she has experienced during the gameplay. When this is the case, the researcher and/or the anesthesiologist should make a remark on the observation form. Even if this is the case, the objective observation and scoring on the scale should continue as planned.

Study Type

Interventional

Enrollment (Anticipated)

164

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 7 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children from 4 up to (and included) 7 years old. The children represent a large group within the otorhinolaryngeal discipline and these children are within the same cognitive phase when it comes to playing a serious game
  • Children who need otorhinolaryngeal surgery for the first time.
  • Children and at least one of the parents are able to comprehend and speak the Dutch language.
  • Children who will receive a mask induction of the anaesthesia.

Exclusion Criteria:

  • Older and younger children than the mentioned age group.
  • Children who do not have a complete comprehension of the Dutch language. Children will not be excluded based on cultural or background information.
  • Children who had previous surgical experiences both elective or urgent.
  • The following children will also be excluded from participation: children with mental retardation, children that have had opioids or sedative during the past month, children with early birth, children with behavioural dysfunction and children with a delayed cognitive development.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: HospiAvontuur
Intervention group - Non-pharmacological (HospiAvontuur) preparation HospiAvontuur is a simple point and click adventure game on a I-pad. The game describes the pathway which a child and his parents will take before, during and just after a hospital admission for an elective otorhinolaryngeal procedure under general anaesthesia.
To be included in the study children should play the game at least one time together with one parent
Other Names:
  • Tablet application
ACTIVE_COMPARATOR: Midazolam
control group: The children of the control group will not play the game HospiAvontuur as an at home preparation for surgery. These children will be prepared for surgery according to the current practice at the Jessa hospital. Children receive only the basic information during the consultation with the surgeon. There is no specific at home preparation required. When admitted at the hospital, children receive a pharmacological preparation, 45 - 60 minutes prior to the induction of the anaesthesia. The medication is administered orally by a small syringe in the mouth and contains Dormicum 0.3mg/kg body weight and atropine 0.02mg/kg body weight supplemented with raspberry syrup.
current practice in Jessa
Other Names:
  • Anxiolytic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mYPAS-SF (pre-operative)
Time Frame: At baseline: at the beginning of the preoperative process
For the measurement of the state anxiety, the mYPAS-SF (attachment 3) (modified Yale Preoperative Anxiety Scale - Short Version) will be used. In previous research projects usually the mYPAS (attachment 4) is used. The mYPAS was developed in 1995 (Kain et al, 1995) and modified in 1997 (Kain et al, 1997). It has been used in more than 100 studies spanning diverse health fields, such as anesthesia, surgery, paediatrics and dentistry (Cuzzocrea et al, 2013; Davidson et al, 2006; Huet et al, 2011; Weldon et al, 2004; Fortier et al, 2009; Fortier et al, 2010). This measurement instrument uses 5 items, each representing a different domain of child anxiety, and is used at 4 points in time during the preoperative phase. These 4 time points are: preoperative holding, walk to the OR, entrance to the OR (child enters the OR but has not yet seen the anesthesia mask), and introduction to the anesthesia mask (Jenkins et al, 2014).
At baseline: at the beginning of the preoperative process

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAK 4-12 (Vragenlijst Angst Kinderen) for anxiety (pre-operative)
Time Frame: Up to two weeks before baseline measurement: the VAK4-12 will be completed at home, before any intervention has taken place.
In order to determine any baseline imbalances between the research groups, the VAK4-12 questionnaire will be used. The VAK4-12 (Vragenlijst Angst Kinderen) is a Dutch questionnaire to determine the level of subjective experienced fear in children of 4-6 years old (trait anxiety). It is a reconstructed version of the Revised Fear Survey Schedule for Children. The scale offers scores on 5 subscales and can be completed by children and their parent(s) together. It is a scale which is easy to complete and takes about 20 minutes. In scientific research this questionnaire can be used to select anxious and non-anxious children. It can also be used in effectiveness studies for interventions which focus on anxiety reduction.
Up to two weeks before baseline measurement: the VAK4-12 will be completed at home, before any intervention has taken place.
ICC (pre-operative)
Time Frame: At baseline: at the beginning of the preoperative process
The ICC (Induction Compliance Checklist) is an observational checklist for describing the compliance of a child towards the induction of general anaesthesia. The checklist consists of 11 items which indicate the compliance. The ICC score is the sum of the items checked. A perfect induction, during which the child does not show negative behaviors, fear or anxiety is scored as 0. This instrument was developed by the research group of Kain et al (1998).
At baseline: at the beginning of the preoperative process
PAEDS (Pediatric Anxiety Emergency delirium Scale) (post-operative)
Time Frame: Immediately after surgery
The PAED (Pediatric Anesthesia Emergence Delirium Scale) is an observational checklist for describing emergence delirium in the postoperative phase. The scale incorporates cognitive and agitation assessment items and is generally acknowledged to be the most valid and reliable. A score of 10 or above has the highest diagnostic sensitivity and specificity (Bong CL, Ng AS, 2009; Janseen NJ, Tan EY, Staal M, et al, 2011).
Immediately after surgery
OPS (Objective Pain Score) (Post-operative)
Time Frame: Immediately after surgery
The OPS (Objective Pain Score) is an observational scale for postoperative pain measurement. The scale is a good stand-alone tool to scale pain and to ascertain the need for analgesia and is a good tool to refer to when the NRS is indicative of mild or moderate pain (Tandom M. et al, 2016). At this moment the scale is the standard used instrument in the recovery room.
Immediately after surgery
Faces Pain Scale - Revised (FPS-R) (post-operative)
Time Frame: After 2 days and after 1 week of surgery
The Faces Pain Scale - Revised (FPS-R) (Hicks CL, von Baeyer CL, Spafford P., et al, 2001) is a self-report measure of pain intensity developed for children. It was adapted from the Faces Pain Scale (Bieri D., Reeve R., Champion GD., et al., 1990) to make it possible to score the sensation of pain on the widely accepted 0-to-10 metric. The scale shows a close linear relationship with visual analog pain scales across the age range of 4-16 years. It is easy to administer and requires no equipment except for the photocopied faces.
After 2 days and after 1 week of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Annemie IF Spooren, PhD, PXL University College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2017

Primary Completion (ANTICIPATED)

May 30, 2019

Study Completion (ANTICIPATED)

July 30, 2019

Study Registration Dates

First Submitted

November 20, 2017

First Submitted That Met QC Criteria

September 11, 2018

First Posted (ACTUAL)

September 14, 2018

Study Record Updates

Last Update Posted (ACTUAL)

November 20, 2018

Last Update Submitted That Met QC Criteria

November 18, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

3
Subscribe